Beyond skin white spots: Vitiligo and associated comorbidities

Vitiligo is a common depigmentation disorder of an unknown origin characterized by the selective loss of melanocytes, resulting in typical white macules and patches. However, vitiligo is now recognized as more than just a skin disease, what a dermatologist observes as a white spot of skin is just th...

Full description

Bibliographic Details
Published in:	Frontiers in Medicine
Main Authors:	Zhonghui Hu, Tao Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Subjects:	Vitiligo comorbidities etiology pathogenesis melanocytes
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1072837/full

Similar Items

A child with vitiligo
by: Monika Prylińska, et al.
Published: (2021-09-01)

Melanocyte Function and Count of Leukotrichia in Vitiligo Using S100 Immunohistochemistry and Microphtalmia Associated Transcription Factor (MITF)
by: M. Yulianto Listiawan, et al.
Published: (2017-01-01)

Vitiligo: modern methods of therapy
by: Talnikova Е.Е., et al.
Published: (2017-09-01)

Failure of non-cultured melanocyte–keratinocyte transplantation in periungual vitiligo: A case report
by: Norah Alsubait, et al.
Published: (2015-07-01)

Dysregulated Intracellular Signaling in the Pathogenesis of Vitiligo: An Update on Emerging Therapeutic Strategies
by: Ramona Marrapodi, et al.
Published: (2025-09-01)

Advances in the etiopathogenesis of vitiligo
by: Thomas Mathew, et al.
Published: (2024-12-01)

Melanogenesis and hypopigmentation: The case of vitiligo
by: M Pilar Vinardell, et al.
Published: (2022-01-01)

Understanding the molecular basis of vitiligo - a systematic review
by: Magdalena Osuch, et al.
Published: (2023-08-01)

Evaluation of auditory system in vitiligo patients: A case-control study
by: Sima Tajik, et al.
Published: (2024-11-01)

Vitiligo Review: etiopathogenesis, diagnosis and treatment
by: Aleksandra Witek, et al.
Published: (2025-01-01)

Melanocyte transplantation to skin prepared by controlled PUVA-induced sunburn-like blistering for vitiligo treatment – A pilot clinical trial
by: Po-Hua Chen, et al.
Published: (2024-08-01)

Role of HMGB1 in Vitiligo: Current Perceptions and Future Perspectives
by: Wei G, et al.
Published: (2022-10-01)

The Efficacy of an Innovative Method of Melanocytes-Keratinocytes Suspension for the Treatment of Stable Vitiligo (A Report of 20 Cases)
by: Fariba Jaffary, et al.
Published: (2016-04-01)

Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic Strategies
by: Artur Kovenskiy, et al.
Published: (2024-12-01)

Vitiligo: A Review of Aetiology, Pathogenesis, Treatment, and Psychosocial Impact
by: Khadeejeh AL-smadi, et al.
Published: (2023-05-01)

Immune Activities in Choroids of Visually Impaired Smyth Chickens With Autoimmune Vitiligo
by: Jordan Sorrick, et al.
Published: (2022-04-01)

The antioxidant stress effect of granulin precursor in vitiligo
by: Haoran Guo, et al.
Published: (2025-05-01)

Regenerative Medicine-Based Treatment for Vitiligo: An Overview
by: Barbara Bellei, et al.
Published: (2022-10-01)

Ocular manifestations of vitiligo: a systematic review
by: Tessa LeWitt, et al.
Published: (2023-03-01)

Histopathological differences between vitiligo and lichen sclerosus et atrophicus using quantitative immunohistochemical analysis
by: Young Joon Park, et al.
Published: (2023-07-01)

Aetiopathogenesis of Vitiligo
by: Katia Boniface
Published: (2023-12-01)

A survey study of self‐reported comorbidities among adults with vitiligo in the United States
by: Khaled Ezzedine, et al.
Published: (2023-06-01)

The Effect of Fractional Carbon Dioxide Laser on Melanogenesis in Human Melanocytes and Vitiligo Mouse Models
by: Tang H, et al.
Published: (2024-08-01)

Vitiligo – from clinical manifestations to pathophysiological mechanisms and cell death
by: Ana Maria Chivu, et al.
Published: (2021-06-01)

A Simple Drug Delivery System for Platelet-Derived Bioactive Molecules, to Improve Melanocyte Stimulation in Vitiligo Treatment
by: Karolina Vocetkova, et al.
Published: (2020-09-01)

Medical treatment of vitiligo: A narrative review
by: Anuradha Bishnoi, et al.
Published: (2024-12-01)

Potential of regenerative medicine for treatment of vitiligo patients
by: A. A. Kubanova, et al.
Published: (2017-08-01)

Recent Advances in Management of Vitiligo
by: Kinnor Das, et al.
Published: (2025-07-01)

Vitiligo: Clinical and Laboratory Characteristics in 573 Saudi Patients.
by: AlJasser MI
Published: (2024-12-01)

A 4-year follow-up study of 20 cases of stable localized childhood vitiligo treated by autologous, noncultured melanocyte–keratinocyte cell transplantation
by: Ettappurath N Abdul Latheef, et al.
Published: (2023-01-01)

Comorbidity Burden Among Patients with Vitiligo in the United States: A Large-Scale Retrospective Claims Database Analysis
by: Khaled Ezzedine, et al.
Published: (2023-09-01)

Surgical management of vitiligo - An approach to the patient
by: K Manchanda, et al.
Published: (2013-04-01)

Surgical management of vitiligo - An approach to the patient
by: K Manchanda, et al.
Published: (2013-04-01)

The immunological pathogenesis of vitiligo and the potential role of mesenchymal stromal/stem cells in its treatment
by: Rui-Lin Yang, et al.
Published: (2025-07-01)

Giant congenital melanocytic nevus with neurofibroma-like lesions and onset of vitiligo
by: Iman Hadj, et al.
Published: (2015-01-01)

A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPARγ Agonist
by: Federica Papaccio, et al.
Published: (2022-11-01)

Advanced Therapy Medicinal Products in Vitiligo; Current Status, Future Prospect, and Approved Treatments
by: Shahriar Ghashghaei, et al.
Published: (2023-03-01)

A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis
by: Shahnawaz D. Jadeja, et al.
Published: (2021-02-01)

Low-Dose Melittin Enhanced Pigment Production Through the Upregulation of Tyrosinase Activity and Dendricity in Melanocytes by Limiting Oxidative Stress: A Therapeutic Implication for Vitiligo
by: Manoj Kumar Tembhre, et al.
Published: (2024-11-01)

Serum IFN-γ is increased in patients with active vitiligo
by: ZHAO Xiao-ling, HE Run-zhi, SUN Yu-jiao, ZHANG Xiao-chong, YANG Lin-fang, WANG Rui, CHENG Fang
Published: (2022-07-01)